配色: 字号:
良性前列腺增生合并慢性前列腺炎的临床特点分析_常德贵
2020-12-09 | 阅:  转:  |  分享 
  
),4,,,481,18,,,10(01,)3746097(5,(19020,,3,,6,00,07,070562)5(9,0616,4)586(09(18,24,3,02408013,76,8848340(416304,,131)5291,,700,20,3,34189,31(,92,)30)6,,29,92,1,1,6,2,32(710141,,7200,,621(9,,42,7,831997)),3(403)212104344021312,2,055,09759302,1(0,,7,,1023),,0,)0(277(4,0391)8,4,0,,52200670,1375,54770,7,04290,5508,),2,,0,,,3,0,68,0,,,026163614221,420)277(39,2,9,,241120,0,23,0,768021261309,0,
NatlJAndrolVol.No.Sep.··
PSA。
BPHBPHCP
PSADBPHCP
BPHPSAD
PSAPSA
PSAD
PSA

Bestinterpretation
AUCSensitivitySpecificity
ofthevalue
f-PSA....
[]...:
t-PSA....
.-.
PSAD....
GuoYLLiHJ.Beijing:RenMinJunYiChuBanShe.
图f-PSA、t-PSA、PSAD项指标的ROC工作曲线分析
-.
[].
Figure.WorkROCcurveanalysisoff-PSAt-PSAandPSAD
.:
-.
BPH
ZhanZKQuWLTianFetal.ZhonghuaMiNiaoWaiKeZa
BPHCPf-PSAt-PSA
Zhi:-.
f-PSA/t-PSAPSAD。
[].
BPHCPBPHf-PSA、t-PSA
β.
:-.
PSADf-PSA/t-PSA。
YangGQLiSWZhengHetal.ZhonghuaNanKeXueZa
BPH
Zhi:-.
PSAf-PSA/t-PSA
[].
PSAD。BPHCP
———.
BPHf-PSA、t-PSAPSAD
:-.
ZhangXHZhangQLiXSetal.ZhonghuaLinChuangYiShi
-
ZaZhiDianZiBan:-.
PSA。
[]BanuNAAzimFAKamalMetal.Inflammationandglandu-
RC
larproliferationinhyperplasticprostates:Associationwithpros-
tatespecificantigenvalue.BangladeshMedResCouncBull
。ROC
:-.
f-PSA、t-PSA、PSAD[].
.:-.
.、.、...
XiaTLDengFMFengT.ZhonghuaYiXueZaZhi
。BPHCP
:-.

[]NadlerRBHumphreyPASmithDSetal.Effectofinflamma-
PSA
tionandbenignprostatichyperplasiaonelevatedserumprostate
。PSAspecificantigenlevels.JUrolPt:-.
[]
[]BensonMCWhangISPantuckAetal.Prostatespecificanti-
BensonPSAD
gendensity:Ameansofdistinguishingbenignprostatichypertro-
PSADPSA
phyandprostatecancer.JUrolPt:-.
:--;:--
:
献花(0)
+1
(本文系金鑫康复堂首藏)